文献速递神经技术与安全US

快速短脉冲超声可均匀递送药物跨越小鼠血脑屏障且破坏轻微

Rapid Short-pulse Ultrasound Delivers Drugs Uniformly across the Murine Blood-Brain Barrier with Negligible Disruption.
PubMed 文献 · Radiology · 2019-03-26

研究使用28只雌性野生型小鼠,比较快速短脉冲超声(1 MHz、5周期、峰值负压0.35 MPa、1.25 kHz速率、0.5 Hz burst)与标准长脉冲(10毫秒、0.5 Hz、声能高150倍)经微泡介导递送模型药物至左侧海马的效果与安全性;快速短脉冲组药物均匀分布于脑实质,微泡声能可预测递送剂量(r=0.97),血脑屏障破坏持续不足10分钟,白蛋白释放较标准长脉冲组少3.4倍,H-E染色未见血管或组织损伤。

要点

  • 快速短脉冲序列(1 MHz、5周期、峰值负压0.35 MPa)递送药物均匀分布于脑实质。
  • 微泡发出的声能可预测递送剂量(r=0.97)。
  • 血脑屏障破坏持续不足10分钟,白蛋白释放较标准长脉冲少3.4倍,H-E染色未见血管或组织损伤。

核心结论

  • 快速短脉冲超声序列是一种破坏性最小且高效的药物递送方法,可能改善神经系统疾病的治疗、诊断和研究。

研究设计与样本

  • 研究使用28只雌性野生型小鼠,于2017年5月至11月进行聚焦超声处理,注射微泡和标记的模型药物;3只对照小鼠未处理;14只小鼠左侧海马接受快速短脉冲超声(1 MHz、5周期、峰值负压0.35 MPa、1.25 kHz速率、0.5 Hz burst),另14只接受标准长脉冲(10毫秒、0.5 Hz、声能高150倍);超声后0分钟(n=5)、10分钟(n=3)、20分钟(n=3)处死小鼠;3只小鼠行H-E染色;采用归一化光密度和变异系数量化递送剂量与分布;安全性通过H-E染色、白蛋白释放量和血脑屏障通透性改变持续时间评估;统计采用Student t检验。

关键影像表现/征象

  • 快速短脉冲序列递送药物均匀分布于脑实质;血脑屏障破坏持续不足10分钟;H-E染色未见快速短脉冲暴露导致的血管或组织损伤。

诊断标准与关键数值

  • 微泡发出的声能可预测递送剂量(r=0.97);快速短脉冲组白蛋白释放量较标准长脉冲组少3.4倍。

临床应用与阅片要点

  • 快速短脉冲超声序列是一种破坏性最小且高效的药物递送方法,可能改善神经系统疾病的治疗、诊断和研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Previous work has demonstrated that drugs can be delivered across the blood-brain barrier by exposing circulating microbubbles to a sequence of long ultrasound pulses. Although this sequence has successfully delivered drugs to the brain, concerns remain regarding potentially harmful effects from disrupting the brain vasculature. Purpose To determine whether a low-energy, rapid, short-pulse ultrasound sequence can efficiently and safely deliver drugs to the murine brain. Materials and Methods Twenty-eight female wild-type mice underwent focused ultrasound treatment after injections of microbubbles and a labeled model drug, while three control mice were not treated (May-November 2017). The left hippocampus of 14 mice was exposed to low-energy short pulses (1 MHz; five cycles; peak negative pressure, 0.35 MPa) of ultrasound emitted at a rapid rate (1.25 kHz) in bursts (0.5 Hz), and another 14 mice were exposed to standard long pulses (10 msec, 0.5 Hz) containing 150 times more acoustic energy. Mice were humanely killed at 0 (n = 5), 10 (n = 3), or 20 minutes (n = 3) after ultrasound treatment. Hematoxylin-eosin (H-E) staining was performed on three mice. The delivered drug dose and distribution were quantified with the normalized optical density and coefficient of variation. Safety was assessed by H-E staining, the amount of albumin released, and the duration of permeability change in the blood-brain barrier. Statistical analysis was performed by using the Student t test. Results The rapid short-pulse sequence delivered drugs uniformly throughout the parenchyma. The acoustic energy emitted from the microbubbles also predicted the delivered dose (r = 0.97). Disruption in the blood-brain barrier lasted less than 10 minutes and 3.4-fold less albumin was released into the brain than with long pulses. No vascular or tissue damage from rapid short-pulse exposure was observable using H-E staining. Conclusion The rapid short-pulse ultrasound sequence is a minimally disruptive and efficient drug delivery method that could improve the treatment, diagnosis, and study of neurologic diseases. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Klibanov and McDannold in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Morse SV, Pouliopoulos AN, Chan TG, et al. Rapid Short-pulse Ultrasound Delivers Drugs Uniformly across the Murine Blood-Brain Barrier with Negligible Disruption. Radiology. 2019. PMID: 30912718. doi:10.1148/radiol.2019181625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。